AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koh, D.-M.
Right arrow Articles by Husband, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koh, D.-M.
Right arrow Articles by Husband, J. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Diagnostic Accuracy of Rim and Segmental MRI Enhancement of Colorectal Hepatic Metastasis After Administration of Mangafodipir Trisodium

Dow-Mu Koh1, Gina Brown1, Ziad Meer2, Andrew R. Norman3 and Janet E. Husband1

1 Academic Department of Radiology, Royal Marsden Hospital, Downs Rd., Sutton, Surrey, United Kingdom SM2 5PT.
2 Department of Radiology, Hillingdon Hospital, Pield Health Rd., Middlesex, United Kingdom UB8 3NN.
3 Department of Medical Statistics, Royal Marsden Hospital, Downs Rd., Sutton, Surrey, United Kingdom SM3 6AL.


Figure 1
View larger version (108K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A —Images from early phase of mangafodipir trisodium-enhanced T1-weighted MRI show border characteristics of lesions. Insets are diagrams of findings. Smooth border characterized by smooth contour without considerable irregularity or protrusions.

 

Figure 2
View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B —Images from early phase of mangafodipir trisodium-enhanced T1-weighted MRI show border characteristics of lesions. Insets are diagrams of findings. Blurred border characterized by ill-defined outline of lesion.

 

Figure 3
View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C —Images from early phase of mangafodipir trisodium-enhanced T1-weighted MRI show border characteristics of lesions. Insets are diagrams of findings. Irregular border characterized by jagged contour.

 

Figure 4
View larger version (111K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1D —Images from early phase of mangafodipir trisodium-enhanced T1-weighted MRI show border characteristics of lesions. Insets are diagrams of findings. Irregular border with satellitism recorded for lesion with irregular outline associated with smaller nodules in periphery.

 

Figure 5
View larger version (11K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 —Diagram shows histopathologic and follow-up imaging validation of lesions detected with mangafodipir trisodium (MnDPDP)-enhanced MRI.

 

Figure 6
View larger version (127K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A —63-year-old man with rim-enhancing hepatic metastasis. Unenhanced T1-weighted image shows 2-cm metastatic lesion hypointense in relation to hepatic parenchyma.

 

Figure 7
View larger version (134K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B —63-year-old man with rim-enhancing hepatic metastasis. T1-weighted MR image (TR/TE, 128/4.6) obtained 30 minutes after administration of mangafodipir trisodium shows lesion with irregular border and faint rim enhancement.

 

Figure 8
View larger version (143K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3C —63-year-old man with rim-enhancing hepatic metastasis. T1-weighted MR image obtained 24 hours after administration of mangafodipir trisodium and after washout of contrast agent from hepatic parenchyma shows rim enhancement better than does B.

 

Figure 9
View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A —48-year-old woman with small rim-enhancing hepatic metastasis. Axial T1-weighted images 30 minutes (A) and 24 hours (B) after administration of mangafodipir trisodium contrast medium. Rim enhancement highlights presence of small (2 mm) metastatic lesions (arrows) within right lobe of liver. Patient refused surgery.

 

Figure 10
View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B —48-year-old woman with small rim-enhancing hepatic metastasis. Axial T1-weighted images 30 minutes (A) and 24 hours (B) after administration of mangafodipir trisodium contrast medium. Rim enhancement highlights presence of small (2 mm) metastatic lesions (arrows) within right lobe of liver. Patient refused surgery.

 

Figure 11
View larger version (135K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4C —48-year-old woman with small rim-enhancing hepatic metastasis. Contrast-enhanced CT image 4 months after A and B shows disease progression.

 

Figure 12
View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5A —58-year-old man with segmental enhancement pattern of hepatic metastasis. T1-weighted MR image obtained 30 minutes after mangafodipir trisodium administration shows irregular metastatic lesion in left lobe of liver.

 

Figure 13
View larger version (147K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5B —58-year-old man with segmental enhancement pattern of hepatic metastasis. T1-weighted MR image obtained 24 hours after mangafodipir trisodium administration shows normal clearance of contrast agent from right lobe of liver, but persistent segmental hyperintensity (arrowheads) is present within segment II of left lobe. Rim enhancement in this case is not discernible because of presence of segmental enhancement.

 

Figure 14
View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6A —50-year-old man with segmental enhancement caused by small metastatic lesion. Preoperative contrast-enhanced axial CT image obtained in portal venous phase shows no evidence of disease in superior portion of right lobe of liver.

 

Figure 15
View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6B —50-year-old man with segmental enhancement caused by small metastatic lesion. T1-weighted axial MR images obtained 30 minutes (B) and 24 hours (C) after contrast administration show segmental enhancement on delayed scan. Small (2-mm) metastatic lesion at apex of segmental enhancement (arrow, C) was confirmed at histopathologic examination.

 

Figure 16
View larger version (143K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6C —50-year-old man with segmental enhancement caused by small metastatic lesion. T1-weighted axial MR images obtained 30 minutes (B) and 24 hours (C) after contrast administration show segmental enhancement on delayed scan. Small (2-mm) metastatic lesion at apex of segmental enhancement (arrow, C) was confirmed at histopathologic examination.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.